Waste Management
Compare Stocks
5 / 10Stock Comparison
LNZA vs LOOP vs GEVO vs AMTX vs CLNE
Revenue, margins, valuation, and 5-year total return — side by side.
Chemicals - Specialty
Chemicals - Specialty
Oil & Gas Refining & Marketing
Oil & Gas Refining & Marketing
LNZA vs LOOP vs GEVO vs AMTX vs CLNE — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Waste Management | Chemicals - Specialty | Chemicals - Specialty | Oil & Gas Refining & Marketing | Oil & Gas Refining & Marketing |
| Market Cap | $53M | $68M | $493M | $213M | $507M |
| Revenue (TTM) | $40M | $11M | $174M | $209M | $439M |
| Net Income (TTM) | $-76M | $-3M | $-11M | $-74M | $-99M |
| Gross Margin | 29.0% | 96.3% | 23.4% | 3.4% | 11.7% |
| Operating Margin | -265.8% | -3.2% | -4.6% | -13.4% | 7.4% |
| Total Debt | $82M | $3M | $168M | $318M | $99M |
| Cash & Equiv. | $43M | $13M | $1M | $5M | $158M |
LNZA vs LOOP vs GEVO vs AMTX vs CLNE — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Sep 21 | May 26 | Return |
|---|---|---|---|
| LanzaTech Global, I… (LNZA) | 100 | 2.3 | -97.7% |
| Loop Industries, In… (LOOP) | 100 | 12.3 | -87.7% |
| Gevo, Inc. (GEVO) | 100 | 30.6 | -69.4% |
| Aemetis, Inc. (AMTX) | 100 | 17.1 | -82.9% |
| Clean Energy Fuels … (CLNE) | 100 | 28.3 | -71.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: LNZA vs LOOP vs GEVO vs AMTX vs CLNE
Each card shows where this stock fits in a portfolio — not just who wins on paper.
LNZA lags the leaders in this set but could rank higher in a more targeted comparison.
LOOP carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.
- beta 0.89
- Lower volatility, beta 0.89, current ratio 3.50x
- Beta 0.89, current ratio 3.50x
- 70.2% revenue growth vs AMTX's -22.3%
GEVO is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 8.5%, EPS growth 58.8%, 3Y rev CAGR 415.1%
- -6.6% margin vs LNZA's -190.2%
- -1.7% ROA vs LNZA's -58.8%, ROIC -2.8% vs -147.7%
AMTX ranks third and is worth considering specifically for long-term compounding.
- 31.1% 10Y total return vs CLNE's -26.9%
- +140.0% vs LNZA's -5.2%
Among these 5 stocks, CLNE doesn't own a clear edge in any measured category.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 70.2% revenue growth vs AMTX's -22.3% | |
| Quality / Margins | -6.6% margin vs LNZA's -190.2% | |
| Stability / Safety | Beta 0.89 vs LNZA's 1.64 | |
| Dividends | Tie | None of these 5 stocks pay a meaningful dividend |
| Momentum (1Y) | +140.0% vs LNZA's -5.2% | |
| Efficiency (ROA) | -1.7% ROA vs LNZA's -58.8%, ROIC -2.8% vs -147.7% |
LNZA vs LOOP vs GEVO vs AMTX vs CLNE — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
LNZA vs LOOP vs GEVO vs AMTX vs CLNE — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CLNE leads in 1 of 6 categories
GEVO leads 1 • LNZA leads 0 • LOOP leads 0 • AMTX leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — LOOP and CLNE each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CLNE is the larger business by revenue, generating $439M annually — 39.4x LOOP's $11M. GEVO is the more profitable business, keeping -6.6% of every revenue dollar as net income compared to LNZA's -190.2%. On growth, LOOP holds the edge at +65.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $40M | $11M | $174M | $209M | $439M |
| EBITDAEarnings before interest/tax | -$102M | $63,000 | $18M | -$21M | $62M |
| Net IncomeAfter-tax profit | -$76M | -$3M | -$11M | -$74M | -$99M |
| Free Cash FlowCash after capex | -$81M | -$404,000 | -$35M | -$38M | $19M |
| Gross MarginGross profit ÷ Revenue | +29.0% | +96.3% | +23.4% | +3.4% | +11.7% |
| Operating MarginEBIT ÷ Revenue | -2.7% | -3.2% | -4.6% | -13.4% | +7.4% |
| Net MarginNet income ÷ Revenue | -190.2% | -24.3% | -6.6% | -35.4% | -22.7% |
| FCF MarginFCF ÷ Revenue | -2.0% | -3.6% | -19.9% | -18.2% | +4.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | -6.7% | +65.4% | +47.5% | +27.4% | +13.3% |
| EPS Growth (YoY)Latest quarter vs prior year | +103.4% | +76.0% | +3.8% | +29.8% | +90.0% |
Valuation Metrics
CLNE leads this category, winning 2 of 4 comparable metrics.
Valuation Metrics
On an enterprise value basis, CLNE's 94.6x EV/EBITDA is more attractive than GEVO's 102.1x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $53M | $68M | $493M | $213M | $507M |
| Enterprise ValueMkt cap + debt − cash | $91M | $58M | $659M | $526M | $448M |
| Trailing P/EPrice ÷ TTM EPS | -0.32x | -4.46x | -14.50x | -2.44x | -2.29x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | — | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | — |
| EV / EBITDAEnterprise value multiple | — | — | 102.12x | — | 94.64x |
| Price / SalesMarket cap ÷ Revenue | 1.06x | 6.26x | 3.07x | 1.02x | 1.19x |
| Price / BookPrice ÷ Book value/share | 3.33x | 182.83x | 1.01x | — | 0.90x |
| Price / FCFMarket cap ÷ FCF | — | — | — | — | 8.47x |
Profitability & Efficiency
GEVO leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
GEVO delivers a -2.4% return on equity — every $100 of shareholder capital generates $-2 in annual profit, vs $-2 for LNZA. CLNE carries lower financial leverage with a 0.18x debt-to-equity ratio, signaling a more conservative balance sheet compared to LOOP's 8.41x. On the Piotroski fundamental quality scale (0–9), CLNE scores 5/9 vs LNZA's 3/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -2.2% | -2.1% | -2.4% | — | -17.2% |
| ROA (TTM)Return on assets | -58.8% | -24.0% | -1.7% | -29.3% | -9.2% |
| ROICReturn on invested capital | -147.7% | -8.7% | -2.8% | -70.3% | -9.4% |
| ROCEReturn on capital employed | -60.8% | -35.0% | -3.1% | -19.0% | -9.4% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 4 | 4 | 4 | 5 |
| Debt / EquityFinancial leverage | 6.09x | 8.41x | 0.36x | — | 0.18x |
| Net DebtTotal debt minus cash | $38M | -$10M | $166M | $313M | -$59M |
| Cash & Equiv.Liquid assets | $43M | $13M | $1M | $5M | $158M |
| Total DebtShort + long-term debt | $82M | $3M | $168M | $318M | $99M |
| Interest CoverageEBIT ÷ Interest expense | — | -0.69x | -0.04x | -0.27x | -1.07x |
Total Returns (Dividends Reinvested)
Evenly matched — GEVO and AMTX each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in GEVO five years ago would be worth $3,476 today (with dividends reinvested), compared to $229 for LNZA. Over the past 12 months, AMTX leads with a +140.0% total return vs LNZA's -5.2%. The 3-year compound annual growth rate (CAGR) favors GEVO at 18.2% vs LNZA's -59.7% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +61.8% | +38.9% | -1.5% | +96.2% | +6.9% |
| 1-Year ReturnPast 12 months | -5.2% | +42.4% | +88.0% | +140.0% | +44.4% |
| 3-Year ReturnCumulative with dividends | -93.4% | -55.2% | +65.0% | +37.4% | -46.3% |
| 5-Year ReturnCumulative with dividends | -97.7% | -83.5% | -65.2% | -76.1% | -73.8% |
| 10-Year ReturnCumulative with dividends | -97.7% | -90.8% | -98.6% | +31.1% | -26.9% |
| CAGR (3Y)Annualised 3-year return | -59.7% | -23.5% | +18.2% | +11.2% | -18.7% |
Risk & Volatility
Evenly matched — LOOP and AMTX each lead in 1 of 2 comparable metrics.
Risk & Volatility
LOOP is the less volatile stock with a 0.89 beta — it tends to amplify market swings less than LNZA's 1.64 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. AMTX currently trades 82.1% from its 52-week high vs LNZA's 31.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.64x | 0.89x | 1.64x | 1.46x | 1.19x |
| 52-Week HighHighest price in past year | $71.19 | $2.29 | $2.97 | $3.80 | $3.11 |
| 52-Week LowLowest price in past year | $7.88 | $0.85 | $1.01 | $1.22 | $1.56 |
| % of 52W HighCurrent price vs 52-week peak | +31.8% | +61.6% | +68.4% | +82.1% | +74.3% |
| RSI (14)Momentum oscillator 0–100 | 46.1 | 55.6 | 53.5 | 58.2 | 44.6 |
| Avg Volume (50D)Average daily shares traded | 49K | 74K | 4.5M | 1.8M | 1.3M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Analyst consensus: LNZA as "Hold", GEVO as "Buy", AMTX as "Buy", CLNE as "Buy". Consensus price targets imply 72.4% upside for GEVO (target: $4) vs -75.7% for LNZA (target: $6).
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | — | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $5.50 | — | $3.50 | $1.75 | $3.50 |
| # AnalystsCovering analysts | 4 | — | 14 | 7 | 22 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — | — |
| Dividend StreakConsecutive years of raises | 1 | — | — | — | — |
| Dividend / ShareAnnual DPS | — | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +0.1% | 0.0% | 0.0% | 0.0% | +1.6% |
CLNE leads in 1 of 6 categories (Valuation Metrics). GEVO leads in 1 (Profitability & Efficiency). 3 tied.
LNZA vs LOOP vs GEVO vs AMTX vs CLNE: Key Questions Answered
8 questions · data-driven answers · updated daily
01Is LNZA or LOOP or GEVO or AMTX or CLNE a better buy right now?
For growth investors, Loop Industries, Inc.
(LOOP) is the stronger pick with 70. 2% revenue growth year-over-year, versus -22. 3% for Aemetis, Inc. (AMTX). Analysts rate Gevo, Inc. (GEVO) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — LNZA or LOOP or GEVO or AMTX or CLNE?
Over the past 5 years, Gevo, Inc.
(GEVO) delivered a total return of -65. 2%, compared to -97. 7% for LanzaTech Global, Inc. (LNZA). Over 10 years, the gap is even starker: AMTX returned +31. 1% versus GEVO's -98. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — LNZA or LOOP or GEVO or AMTX or CLNE?
By beta (market sensitivity over 5 years), Loop Industries, Inc.
(LOOP) is the lower-risk stock at 0. 89β versus LanzaTech Global, Inc. 's 1. 64β — meaning LNZA is approximately 85% more volatile than LOOP relative to the S&P 500. On balance sheet safety, Clean Energy Fuels Corp. (CLNE) carries a lower debt/equity ratio of 18% versus 8% for Loop Industries, Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — LNZA or LOOP or GEVO or AMTX or CLNE?
By revenue growth (latest reported year), Loop Industries, Inc.
(LOOP) is pulling ahead at 70. 2% versus -22. 3% for Aemetis, Inc. (AMTX). On earnings-per-share growth, the picture is similar: Gevo, Inc. grew EPS 58. 8% year-over-year, compared to -173. 0% for Clean Energy Fuels Corp.. Over a 3-year CAGR, GEVO leads at 415. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — LNZA or LOOP or GEVO or AMTX or CLNE?
Gevo, Inc.
(GEVO) is the more profitable company, earning -21. 1% net margin versus -277. 7% for LanzaTech Global, Inc. — meaning it keeps -21. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: GEVO leads at -11. 7% versus -219. 7% for LNZA. At the gross margin level — before operating expenses — LOOP leads at 95. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — LNZA or LOOP or GEVO or AMTX or CLNE?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
07Is LNZA or LOOP or GEVO or AMTX or CLNE better for a retirement portfolio?
For long-horizon retirement investors, Loop Industries, Inc.
(LOOP) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 89)). Gevo, Inc. (GEVO) carries a higher beta of 1. 64 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (LOOP: -90. 8%, GEVO: -98. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between LNZA and LOOP and GEVO and AMTX and CLNE?
These companies operate in different sectors (LNZA (Industrials) and LOOP (Basic Materials) and GEVO (Basic Materials) and AMTX (Energy) and CLNE (Energy)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: LNZA is a small-cap quality compounder stock; LOOP is a small-cap high-growth stock; GEVO is a small-cap high-growth stock; AMTX is a small-cap quality compounder stock; CLNE is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.